BIOAGE LABS, INC. Shares Outstanding (Cover Page)
BIOAGE LABS, INC. (BIOA) had Shares Outstanding (Cover Page) of 45.90 million shares as of 2026-07-31, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-31: Entity Common Stock, Shares Outstanding 45.90M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 44.45M shares.
- 2026-03-19: Entity Common Stock, Shares Outstanding 44.38M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 35.86M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 45.90M shares 10-Q · filed 2026-08-05 |
| 2026-05-01 | 44.45M shares 10-Q · filed 2026-05-08 |
| 2026-03-19 | 44.38M shares 10-K · filed 2026-03-24 |
| 2025-10-31 | 35.86M shares 10-Q · filed 2025-11-06 |
| 2025-08-01 | 35.85M shares 10-Q · filed 2025-08-06 |
| 2025-05-02 | 35.85M shares 10-Q · filed 2025-05-06 |
| 2025-03-17 | 35.85M shares 10-K · filed 2025-03-20 |
| 2024-10-31 | 35.85M shares 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |